You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Human Growth Hormone antibody [GH-Px-2] (ab765)

Overview

  • Product nameAnti-Human Growth Hormone antibody [GH-Px-2]See all Human Growth Hormone primary antibodies ...
  • Description
    Mouse monoclonal [GH-Px-2] to Human Growth Hormone
  • SpecificitySimultaneously binds to human growth hormone and horseradish peroxidase, eliminating the need for a conjugated secondary antibody.
  • Tested applicationsIHC-P, ICC more details
  • Species reactivity
    Reacts with: Human

Properties

Applications

Our Abpromise guarantee covers the use of ab765 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
IHC-P
ICC
  • Application notesICC: Use at an assay dependant dilution.
    IHC-P: Use at an assay dependant concentration.

    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionPlays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues.
    • Involvement in diseaseDefects in GH1 are a cause of growth hormone deficiency isolated type 1A (IGHD1A) [MIM:262400]; also known as pituitary dwarfism I. IGHD1A is an autosomal recessive deficiency of GH which causes short stature. IGHD1A patients have an absence of GH with severe dwarfism and often develop anti-GH antibodies when given exogenous GH.
      Defects in GH1 are a cause of growth hormone deficiency isolated type 1B (IGHD1B) [MIM:612781]; also known as dwarfism of Sindh. IGHD1B is an autosomal recessive deficiency of GH which causes short stature. IGHD1B patients have low but detectable levels of GH. Dwarfism is less severe than in IGHD1A and patients usually respond well to exogenous GH.
      Defects in GH1 are the cause of Kowarski syndrome (KWKS) [MIM:262650]; also known as pituitary dwarfism VI.
      Defects in GH1 are a cause of growth hormone deficiency isolated type 2 (IGHD2) [MIM:173100]. IGHD2 is an autosomal dominant deficiency of GH which causes short stature. Clinical severity is variable. Patients have a positive response and immunologic tolerance to growth hormone therapy.
    • Sequence similaritiesBelongs to the somatotropin/prolactin family.
    • Cellular localizationSecreted.
    • Target information above from: UniProt accession P01241 The UniProt Consortium
      The Universal Protein Resource (UniProt) in 2010
      Nucleic Acids Res. 38:D142-D148 (2010) .

      Information by UniProt
    • Database links
    • Alternative names
        GH 1 antibodyGH antibodyGH N antibody
        GH-N antibodyGH1 antibodyGHN antibodyGHN antibodyGrowth Hormone 1 antibodyGrowth hormone 1 variant 1 antibodyGrowth hormone 1 variant 2 antibodyGrowth hormone antibodyGrowth Hormone Normal antibodyGrowth Hormone Pituitary antibodyGrowth hormone, normal antibodyGrowth hormone, pituitary antibodyHG1 antibodyHG1 antibodyhGH N antibodyhGH-N antibodyHGHN antibodyIGHD1B antibodyPituitary Growth Hormone antibodyRNGHGP antibodySOMA_HUMAN antibodySomatotropin C antibodySomatotropin antibodySomatotropin I Precursor antibody
      see all

    References for Anti-Human Growth Hormone antibody [GH-Px-2] (ab765)

    ab765 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews for ab765.
    Please use the link above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"